Royal Bank of Canada

RBC’s February research update gives institutional investors a clear look at semiconductor upside, commodity volatility, and ESG‑aligned credit and data‑analytics opportunities.

RBC’s upcoming Q1 earnings reveal hidden risks—declining margins, rising losses, and executive ties that may cloud performance and impact small‑business lending. Read our deep dive.

RBC earns a fresh buy rating as analysts praise its robust capital cushion, strong earnings, and AI‑driven growth strategy amid OSFI’s tougher liquidity rules.

RBC’s steady dividend policy, Canadian Tire partnership, and targeted energy research illustrate how the bank balances yield stability with growth in today’s volatile economy.

RBC’s latest U.S. equity research notes upgrade Medline Corp to “moderate buy” and give Phreesia Inc. an “outperform” rating, spotlighting growth in healthcare supply and digital health tech.

RBC’s latest moves—Tesla buy‑ups, quantum‑tech funding and a housing‑market spin—hide hidden conflicts, opaque disclosures and real‑world risks. Discover why regulators, investors and consumers need sharper scrutiny.

RBC’s new prospectus and BMO’s 10% price‑target lift underscore solid growth and robust capital, making the bank a compelling buy for income and growth investors.

RBC’s solid, diversified platform and moderate valuation make it a steady choice for long‑term investors, even as it drives digital wealth, green finance and cross‑border M&A opportunities.

Royal Bank of Canada’s Q3 2025 financials have led to a significant surge in its stock price, driven by record-breaking net income and diversified growth across its financial services and global operations.

Royal Bank of Canada’s stock price remains stable, with a slight increase, while the company introduces a new initiative to support Indigenous Peoples through a no-fee bank account.